- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04184596
Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP) (DExPri)
February 17, 2021 updated by: LinkCare GmbH
The objective of this study is to identify and weight attributes of topic and systemic pain treatment options relevant from the patients' perspective with peripheral neuropathic pain.
The study will use a discrete choice experimental design to reach its objective.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
153
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Baden-Württemberg
-
Stuttgart, Baden-Württemberg, Germany, 70469
- LinkCare GmbH
-
-
Hesse
-
Wiesbaden, Hesse, Germany, 65189
- Schmerz- und Palliativzentrum Rhein-Main
-
Wiesbaden, Hesse, Germany, 65193
- Schmerzpraxis Wiesbaden
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
A total of 150 patients will be included in this study.
Participating centers are outpatient centers, specialist in pain treatment in the state of Hesse.
Description
Inclusion Criteria:
- Patients with diagnosed peripheral neuropathic pain (pNP) as assessed by study sites
Exclusion Criteria:
- Patients with no sufficient knowledge in written or oral German as assessed by study sites
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Stated-Preferences Observational Group
A discrete choice experiment will be conducted with participants with peripheral neuropathic pain in the stated-preferences observational group.
The instrument will measure patient preferences for topical versus systemic pain treatment.
|
An online-based Discrete-Choice Experiment (DCE) using a survey for stated treatment preferences and socio-demographics.
Furthermore, the neuropathic pain component will be assessed in all patients with the Numeric Pain Rating Scale instrument.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient preferences for topical and systemic pain treatment attributes
Time Frame: 20 minutes after survey start
|
Utility values obtained via multinominal logit estimates from discrete choice experiment
|
20 minutes after survey start
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Relevance of attributes attributed with topical and systemic pain treatment
Time Frame: 5 minutes after survey start
|
Derived from Likert scale
|
5 minutes after survey start
|
Marginal rate of substitution against pain reduction
Time Frame: 20 minutes after survey start
|
Derived from discrete choice experiment
|
20 minutes after survey start
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Tino Schubert, MSc, LinkCare GmbH
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 11, 2020
Primary Completion (ACTUAL)
July 30, 2020
Study Completion (ACTUAL)
August 31, 2020
Study Registration Dates
First Submitted
November 29, 2019
First Submitted That Met QC Criteria
November 29, 2019
First Posted (ACTUAL)
December 3, 2019
Study Record Updates
Last Update Posted (ACTUAL)
February 21, 2021
Last Update Submitted That Met QC Criteria
February 17, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VF/1014/1070
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuropathic Pain
-
University Hospital, Clermont-FerrandFondation ApicilCompletedNeuropathic Traumatic Pain | Pain NRS ≥ 4 | Peripheral Neuropathic Pain | Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4France
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPostherpetic Neuralgia (PHN) | Chemotherapy Induced Neuropathic Pain | Diabetic Peripheral Neuropathic Pain (DPN) | HIV-related Neuropathic Pain (HIV)Colombia, Mexico, Ecuador, Peru, Venezuela
-
University Hospital, Strasbourg, FranceTerminatedPostthoracotomy Pain | Postthoracoscopy Neuropathic PainFrance
-
AstraZenecaCompletedNociceptive Pain | Peripheral Neuropathic PainUnited Kingdom
-
University Malaysia SarawakPersatuan Diabetes MalaysiaCompletedNeuropathic Pain, Nociceptive PainMalaysia
-
University Hospital, Clermont-FerrandRecruitingPeripheral Neuropathic PainFrance
-
Daiichi Sankyo Co., Ltd.CompletedCentral Neuropathic PainJapan, Korea, Republic of, Taiwan
-
Hospices Civils de LyonCompletedPharmacoresistant Neuropathic PainFrance
-
Yuhan CorporationCompletedPeripheral Neuropathic PainKorea, Republic of
-
University Hospital, Clermont-FerrandCompletedNeuropathic Pain RebelFrance
Clinical Trials on Discrete Choice Experiment
-
London School of Economics and Political ScienceActive, not recruitingCancerUnited Kingdom
-
Johns Hopkins Bloomberg School of Public HealthPatient-Centered Outcomes Research InstituteUnknownType II DiabetesUnited States
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom
-
Imperial College LondonUniversity of AberdeenCompletedQuality of Life | Surgery | Patient Satisfaction | Health Care Utilization | Prostate Cancer Metastatic | Radiotherapy Side Effect | Urologic CancerUnited Kingdom
-
UNC Lineberger Comprehensive Cancer CenterFogarty International Center of the National Institute of HealthCompletedCervical CancerSouth Africa
-
Leiden University Medical CenterRecruitingUveal MelanomaNetherlands
-
University of North Carolina, Chapel HillCompletedColorectal Cancer | Prostate Cancer | Colon CancerUnited States
-
Stanford UniversityCompletedDevelopmental Disabilities | Fragile X SyndromeUnited States
-
Hospices Civils de LyonCompleted